Nephros Inc. Files 8-K on Financials
Ticker: NEPH · Form: 8-K · Filed: Mar 6, 2025 · CIK: 1196298
| Field | Detail |
|---|---|
| Company | Nephros Inc (NEPH) |
| Form Type | 8-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: NEPH
TL;DR
NEPHROS filed an 8-K for financial updates, check for details.
AI Summary
On March 6, 2025, Nephros, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were provided in the excerpt.
Why It Matters
This filing indicates Nephros, Inc. is providing updates on its financial performance and condition to the SEC, which is important for investors to assess the company's health.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for financial reporting and does not contain any immediately alarming information.
Key Players & Entities
- Nephros, Inc. (company) — Registrant
- March 6, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 380 Lackawanna Place, South Orange, New Jersey 07079 (address) — Principal executive offices
FAQ
What specific financial information is being reported in this 8-K filing?
The provided excerpt states the 8-K concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific figures or content within those sections.
When was this 8-K report filed?
The report was filed on March 6, 2025.
What is the principal business address of Nephros, Inc.?
The principal executive offices are located at 380 Lackawanna Place, South Orange, New Jersey 07079.
What is the state of incorporation for Nephros, Inc.?
Nephros, Inc. is incorporated in Delaware.
What is the SEC file number for Nephros, Inc.?
The SEC file number for Nephros, Inc. is 001-32288.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 6, 2025 regarding NEPHROS INC (NEPH).